WeChat Mini Program
Old Version Features

Nsgo-Ov-Umb1/Engot-Ov30: A Phase Ii Study of Durvalumab in Combination with the Anti-Cd73 Monoclonal Antibody Oleclumab in Patients with Relapsed Ovarian Cancer

M. R. Mirza, L. Tandaric, J. R. Henriksen,J. Maenpaa,R. D. Christensen,M. Waldstrom,K. Lindemann,H. Roed,A. Auranen,L. A. Akslen,L. C. V. Thomsen, S. N. Lindberg,K. Madsen,L. Bjorge

Gynecologic Oncology（2024）

Cited 1|Views5
Key words
Ovarian cancer,Targeted therapy,Oleclumab,Durvalumab
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined